AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33444689 — intervention group
Group type: EXPERIMENTAL
Intervention: tVNS (all areas combined)
Number of subjects: 0
Study 32919098 — intervention group
Group type: EXPERIMENTAL
Intervention: Personally-tailored opioid overdose prevention education and naloxone distribution (PTOEND)
Number of subjects: 80
Study 32919098 — intervention group
Group type: COMPARATOR
Intervention: Control group (Peer recovery support service - PRSS)
Number of subjects: 80
Study 36497804 — intervention group
Group type: EXPERIMENTAL
Intervention: ready4life mobile app-based coaching program for 16 weeks
Number of subjects: 1351
Study 36497804 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1351
Study 34044671 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncoplanar IMRT
Number of subjects: 48
Study 34044671 — intervention group
Group type: COMPARATOR
Intervention: Coplanar IMRT
Number of subjects: 48
Study 32119700 — intervention group
Group type: EXPERIMENTAL
Intervention: New Metal Strips
Number of subjects: 65
Study 32119700 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho‐Strips
Number of subjects: 65
Study 32119700 — intervention group
Group type: EXPERIMENTAL
Intervention: OS discs
Number of subjects: 65
Study 32119700 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe‐Tipped Bur Kit
Number of subjects: 65
Study 32119700 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 65
Study 36317783 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of CIS43LS per kilogram
Number of subjects: 330
Study 36317783 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of CIS43LS per kilogram
Number of subjects: 330
Study 36317783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 32457106 — intervention group
Group type: EXPERIMENTAL
Intervention: SUBA™-Itraconazole (S-ITZ) 2x65 mg TID for 3 days and once on day 4
Number of subjects: 31
Study 32457106 — intervention group
Group type: EXPERIMENTAL
Intervention: SUBA™-Itraconazole (S-ITZ) 2x65 mg BID for 14 days and a last dose on day 15
Number of subjects: 31
Study 32457106 — intervention group
Group type: COMPARATOR
Intervention: Conventional Itraconazole (C-ITZ) 2x100 mg TID for 3 days and once on day 4
Number of subjects: 31
Study 32457106 — intervention group
Group type: COMPARATOR
Intervention: Conventional Itraconazole (C-ITZ) 2x100 mg BID for 14 days and a last dose on day 15
Number of subjects: 31
Study 35610308 — intervention group
Group type: EXPERIMENTAL
Intervention: FCB (Fludarabine + Clofarabine + Busulfan)
Number of subjects: 250
Study 35610308 — intervention group
Group type: COMPARATOR
Intervention: Flu-Bu (Fludarabine + Busulfan)
Number of subjects: 250
Study 35610308 — intervention group
Group type: EXPERIMENTAL
Intervention: FCB
Number of subjects: 250
Study 35610308 — intervention group
Group type: COMPARATOR
Intervention: Flu-Bu
Number of subjects: 250
Study 33386619 — intervention group
Group type: EXPERIMENTAL
Intervention: Forgiveness intervention (twice-a-week sessions for 4 months)
Number of subjects: 16
Study 33386619 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 16
Study 33386619 — intervention group
Group type: EXPERIMENTAL
Intervention: Forgiveness intervention
Number of subjects: 16
Study 35917453 — intervention group
Group type: EXPERIMENTAL
Intervention: GIL + AZA
Number of subjects: 123
Study 35917453 — intervention group
Group type: COMPARATOR
Intervention: AZA
Number of subjects: 123
Study 34491220 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AL)
Number of subjects: 0
Study 34491220 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine (ASAQ)
Number of subjects: 0
Study 34491220 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 0
Study 32657141 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated expressed circular RNAs (DECs) in PDGA
Number of subjects: 0
Study 32657141 — intervention group
Group type: EXPERIMENTAL
Intervention: Top 20 DECs
Number of subjects: 0
Study 32657141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hsa_circRNA_0077837
Number of subjects: 0
Study 35485617 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back method education delivered individually in three sessions of approximately 60 minutes at one-day intervals.
Number of subjects: 58
Study 35485617 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training provided).
Number of subjects: 58
Study 32835356 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU
Number of subjects: 34640
Study 32835356 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 34640
Study 32835356 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPOX
Number of subjects: 34640
Study 32835356 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI
Number of subjects: 34640
Study 32835356 — intervention group
Group type: EXPERIMENTAL
Intervention: capecitabine
Number of subjects: 34640
Study 33608762 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal feedback (PF)
Number of subjects: 203
Study 33608762 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated feedback (AF)
Number of subjects: 203
Study 33608762 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL) control
Number of subjects: 203
Study 32981348 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic increase of 10 mm Hg in diastolic blood pressure
Number of subjects: 7642
Study 32981348 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 7642
Study 32981348 — intervention group
Group type: EXPERIMENTAL
Intervention: 29-variant polygenic risk score (PRS)
Number of subjects: 7642
Study 32981348 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS with family history and smoking risk factors
Number of subjects: 7642
Study 34011467 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (6000 pulses at 20 Hz)
Number of subjects: 29
Study 34011467 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 29
Study 34011467 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 29
Study 33011099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum 1 mg QD (Weeks 1–4)
Number of subjects: 89
Study 33011099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum 5 mg QD (Weeks 1–4)
Number of subjects: 89
Study 33011099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum 20 mg QD (Weeks 5–12)
Number of subjects: 89
Study 33011099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum 20 mg BID (Weeks 5–12)
Number of subjects: 89
Study 33011099 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Weeks 1–4 and 5–12)
Number of subjects: 89
Study 33011099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum
Number of subjects: 89
Study 33609425 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-week nurse-led Internet-based cognitive behavioural therapy for insomnia (I-CBTI) with support
Number of subjects: 48
Study 33609425 — intervention group
Group type: COMPARATOR
Intervention: Internet-based self-study programme without support (control group)
Number of subjects: 48
Study 32267724 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily for 7 days
Number of subjects: 144
Study 32267724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 35063791 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomass cooking fuel
Number of subjects: 600
Study 35063791 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group using other cooking fuels)
Number of subjects: 600
Study 33814126 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 10 mg/day
Number of subjects: 318
Study 33814126 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist (ganirelix 0.25 mg/day)
Number of subjects: 318
Study 34489288 — intervention group
Group type: EXPERIMENTAL
Intervention: Indonesia Drug Addiction Relapse Prevention Programme (Indo-DARPP), a 12-week cognitive behavioural therapy (CBT) and motivational interviewing programme delivered via video-conferencing.
Number of subjects: 220
Study 34489288 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 220
Study 34489288 — intervention group
Group type: EXPERIMENTAL
Intervention: Indonesia Drug Addiction Relapse Prevention Programme (Indo-DARPP)
Number of subjects: 220
Study 33176842 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily for 104 weeks
Number of subjects: 0
Study 33176842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33176842 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily
Number of subjects: 0
Study 36085211 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative DCP
Number of subjects: 761
Study 34152099 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 15
Study 34152099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33876178 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate gestational weight gain (GWG)
Number of subjects: 2331
Study 33876178 — intervention group
Group type: COMPARATOR
Intervention: Inadequate gestational weight gain (GWG)
Number of subjects: 2331
Study 33876178 — intervention group
Group type: EXPERIMENTAL
Intervention: GWG velocity (kg/wk)
Number of subjects: 2331
Study 33876178 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of 0.1 kg/wk in maternal GWG
Number of subjects: 2331
Study 32767227 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile platform measuring pain, emotions, and bodily feelings
Number of subjects: 65
Study 33434512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorlatinib
Number of subjects: 0
Study 33434512 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 0
Study 34510214 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) training
Number of subjects: 128
Study 34510214 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive exercise program (PEP)
Number of subjects: 128
Study 34510214 — intervention group
Group type: COMPARATOR
Intervention: Standard primary care management (PCM)
Number of subjects: 128
Study 34391267 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain inducing massage to the neck
Number of subjects: 60
Study 34391267 — intervention group
Group type: COMPARATOR
Intervention: Cold pressor task to the hand
Number of subjects: 60
Study 34391267 — intervention group
Group type: COMPARATOR
Intervention: Pain free massage to the neck
Number of subjects: 60
Study 32951733 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal cream containing aqueous extract of Achillea millefolium
Number of subjects: 80
Study 32951733 — intervention group
Group type: COMPARATOR
Intervention: Vaginal cream clotrimazole 1%
Number of subjects: 80
Study 36170737 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatrists (PSY)
Number of subjects: 141
Study 36170737 — intervention group
Group type: COMPARATOR
Intervention: Non-Psychiatrist Healthcare Professionals (NPHP)
Number of subjects: 141
Study 36170737 — intervention group
Group type: COMPARATOR
Intervention: Obstetricians-Gynecologists (NPHP subgroup)
Number of subjects: 141
Study 36170737 — intervention group
Group type: COMPARATOR
Intervention: General Practitioners (NPHP subgroup)
Number of subjects: 141
Study 36170737 — intervention group
Group type: COMPARATOR
Intervention: Pediatricians (NPHP subgroup)
Number of subjects: 141
Study 36170737 — intervention group
Group type: COMPARATOR
Intervention: Neurologists (NPHP subgroup)
Number of subjects: 141
Study 34006070 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogeneic cortical plates (XCP group)
Number of subjects: 19
Study 34006070 — intervention group
Group type: COMPARATOR
Intervention: Autogenous cortical plates (ACP group)
Number of subjects: 19
Study 33722947 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 969
Study 33722947 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 969
Study 33722947 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 969
Study 33367487 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes on no medication
Number of subjects: 0
Study 33367487 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes on non-insulin antidiabetic drugs
Number of subjects: 0
Study 33367487 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-treated diabetes
Number of subjects: 0
Study 33032686 — intervention group
Group type: EXPERIMENTAL
Intervention: RFC ablation with prior application of EMLA (Group A)
Number of subjects: 60
Study 33032686 — intervention group
Group type: COMPARATOR
Intervention: RFC ablation without prior application of EMLA (Group B)
Number of subjects: 60
Study 33301361 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard ablation plus elimination of distal CS to LA connections
Number of subjects: 35
Study 33301361 — intervention group
Group type: COMPARATOR
Intervention: Standard ablation (pulmonary vein isolation and nonpulmonary vein trigger ablation)
Number of subjects: 35
Study 32423577 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) training with low weight
Number of subjects: 24
Study 32423577 — intervention group
Group type: COMPARATOR
Intervention: Non-BFR extremity
Number of subjects: 24
Study 35088609 — intervention group
Group type: EXPERIMENTAL
Intervention: IMB model-based education (10-minute online sessions for 7 days)
Number of subjects: 3739
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction and association of the scaphoid and lunate (RASL)
Number of subjects: 15
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-ligament tenodesis (TLT)
Number of subjects: 15
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic front and back (ANAFAB)
Number of subjects: 15
Study 34332817 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 15
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: TLT
Number of subjects: 15
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: RASL
Number of subjects: 15
Study 34332817 — intervention group
Group type: EXPERIMENTAL
Intervention: ANAFAB
Number of subjects: 15
Study 35105626 — intervention group
Group type: EXPERIMENTAL
Intervention: Diquafosol sodium 3% eye-drops
Number of subjects: 42
Study 35105626 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid 0.1% eye-drops
Number of subjects: 42
Study 34091569 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking activity
Number of subjects: 69
Study 34091569 — intervention group
Group type: COMPARATOR
Intervention: Active group
Number of subjects: 69
Study 36330670 — intervention group
Group type: EXPERIMENTAL
Intervention: Block group (collagenated soft-block-type BCP)
Number of subjects: 35
Study 36330670 — intervention group
Group type: COMPARATOR
Intervention: Particle group (particulate BCP)
Number of subjects: 35
Study 36330670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (regardless of BCP type)
Number of subjects: 35
Study 32191203 — intervention group
Group type: EXPERIMENTAL
Intervention: Assigned Evidence‐Based Medicine (EBM) articles and Rosh Review questions
Number of subjects: 0
Study 32191203 — intervention group
Group type: COMPARATOR
Intervention: Textbook readings
Number of subjects: 0
Study 32191203 — intervention group
Group type: EXPERIMENTAL
Intervention: New curriculum (question-based learning and EBM articles)
Number of subjects: 0
Study 34250636 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based childbirth and parenting (MBCP)
Number of subjects: 141
Study 34250636 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual (ECAU)
Number of subjects: 141
Study 33934647 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetrical tibial design (Persona PS)
Number of subjects: 75
Study 33934647 — intervention group
Group type: COMPARATOR
Intervention: Symmetrical tibial design (NexGen LPS)
Number of subjects: 75
Study 33934647 — intervention group
Group type: EXPERIMENTAL
Intervention: Both designs (Asymmetrical and Symmetrical)
Number of subjects: 75
Study 33893022 — intervention group
Group type: EXPERIMENTAL
Intervention: ABSORB bioresorbable vascular scaffold (BVS)
Number of subjects: 286
Study 33893022 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium everolimus-eluting stents
Number of subjects: 286
Study 33051385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness absence due to MDD
Number of subjects: 158813
Study 33051385 — intervention group
Group type: EXPERIMENTAL
Intervention: More severe MDD and longer duration of sickness absence
Number of subjects: 158813
Study 35348360 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care interventions
Number of subjects: 0
Study 33429797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation (PFES)
Number of subjects: 33
Study 32944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast-fermented de-hulled rice (YDR) with sweet grass hay (SGH) at 50-75:50-25 ratio
Number of subjects: 8
Study 32944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast-fermented de-hulled rice (YDR) with untreated rice straw (RS)
Number of subjects: 8
Study 32944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet grass hay (SGH) with YDR ratios
Number of subjects: 8
Study 32944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Different R:YDR ratios (100:0, 75:25, 50:50, 25:75)
Number of subjects: 8
Study 32944871 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet grass hay (SGH) and R:YDR ratios
Number of subjects: 8
Study 34387244 — intervention group
Group type: EXPERIMENTAL
Intervention: Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS) didactic, online module on TeamSTEPPS RRT program, presimulation and postsimulation experience
Number of subjects: 24
Study 34387244 — intervention group
Group type: EXPERIMENTAL
Intervention: RRT rubric assessment
Number of subjects: 24
Study 32921117 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate administration 3 hours before surgery
Number of subjects: 125
Study 32921117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 35177019 — intervention group
Group type: EXPERIMENTAL
Intervention: ACORN intervention + Treatment as usual (TAU)
Number of subjects: 114
Study 35177019 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 114
Study 33368937 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-patch treatment
Number of subjects: 0
Study 33368937 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 33362252 — intervention group
Group type: EXPERIMENTAL
Intervention: GlycoCheck system measurements
Number of subjects: 42
Study 36131308 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent bolus (PIB) of local anaesthetic
Number of subjects: 60
Study 36131308 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of local anaesthetic
Number of subjects: 60
Study 34099033 — intervention group
Group type: EXPERIMENTAL
Intervention: Group skills treatment (stepped-care structured psychological group treatment)
Number of subjects: 0
Study 34099033 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 32816189 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic and resistance training 3×/wk)
Number of subjects: 37
Study 32816189 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 37
Study 34403658 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg + TCS
Number of subjects: 901
Study 34403658 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 30 mg + TCS
Number of subjects: 901
Study 34403658 — intervention group
Group type: COMPARATOR
Intervention: PBO + TCS
Number of subjects: 901
Study 33693732 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous entry using PIQNIQ
Number of subjects: 132
Study 33693732 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo-assisted recall using PIQNIQ
Number of subjects: 132
Study 33693732 — intervention group
Group type: COMPARATOR
Intervention: 24HR (interviewer-assisted 24-h recall)
Number of subjects: 132
Study 32626889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral implant restoration (experimental group)
Number of subjects: 84
Study 32626889 — intervention group
Group type: COMPARATOR
Intervention: Routine methods (control group)
Number of subjects: 84
Study 36311870 — intervention group
Group type: EXPERIMENTAL
Intervention: IV TXA
Number of subjects: 90
Study 36311870 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration of TXA
Number of subjects: 90
Study 36311870 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 36311870 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA (both IV and local)
Number of subjects: 90
Study 33576812 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimagrumab
Number of subjects: 0
Study 33576812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34638190 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral ESPB with 20 ml of 0.375% ropivacaine (group E)
Number of subjects: 40
Study 33346680 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 100
Study 33346680 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 36118696 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Training (VT)
Number of subjects: 54
Study 36118696 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 54
Study 36118696 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 33669985 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian analysis with 0% discounting factor
Number of subjects: 0
Study 33669985 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian analysis with 50% discounting factor
Number of subjects: 0
Study 33669985 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian analysis with 100% discounting factor
Number of subjects: 0
Study 32167230 — intervention group
Group type: EXPERIMENTAL
Intervention: Body hair removal (in women)
Number of subjects: 2510
Study 32167230 — intervention group
Group type: EXPERIMENTAL
Intervention: Body hair removal (in men)
Number of subjects: 2510